Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT189 | Cell Line | Vero | Chlorocebus aethiops | IC50 | = | 0.5 | nM | 10464017 |
NPT1758 | Individual Protein | Hepatitis C virus NS5B RNA-dependent RNA polymerase | Hepatitis C virus | IC50 | = | 22000 | nM | 15084127 |
NPT1758 | Individual Protein | Hepatitis C virus NS5B RNA-dependent RNA polymerase | Hepatitis C virus | EC50 | 46000 | nM | 15084127 | |
NPT190 | Organism | Human herpesvirus 1 | Human herpesvirus 1 | MIC | > | 40 | ug/ml | 1335077 |
NPT1141 | Organism | Human herpesvirus 2 | Human herpesvirus 2 | MIC | > | 40 | ug/ml | 1335077 |
NPT334 | Organism | Vaccinia virus | Vaccinia virus | MIC | > | 100 | ug/ml | 1335077 |
NPT195 | Organism | Vesicular stomatitis virus | Vesicular stomatitis virus | MIC | > | 40 | ug/ml | 1335077 |
NPT195 | Organism | Vesicular stomatitis virus | Vesicular stomatitis virus | MIC | > | 100 | ug/ml | 1335077 |
NPT1106 | Organism | Human poliovirus 1 | Human poliovirus 1 | MIC | > | 100 | ug/ml | 1335077 |
NPT335 | Organism | Human coxsackievirus B4 | Human coxsackievirus B4 | MIC | > | 100 | ug/ml | 1335077 |
NPT336 | Organism | Human parainfluenza virus 3 | Human parainfluenza virus 3 | MIC | > | 100 | ug/ml | 1335077 |
NPT2602 | Organism | Mammalian orthoreovirus 1 | Mammalian orthoreovirus 1 | MIC | > | 100 | ug/ml | 1335077 |
NPT338 | Organism | Sindbis virus | Sindbis virus | MIC | > | 100 | ug/ml | 1335077 |
NPT856 | Organism | Semliki forest virus | Semliki forest virus | MIC | > | 100 | ug/ml | 1335077 |
NPT24 | Organism | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | MIC | > | 4 | ug/ml | 1335077 |
NPT1315 | Individual Protein | Adenosine A1 receptor | Rattus norvegicus | Ki | = | 7120 | nM | 7562934 |
NPT1315 | Individual Protein | Adenosine A1 receptor | Rattus norvegicus | Ki | = | 15200 | nM | 7562934 |
NPT1315 | Individual Protein | Adenosine A1 receptor | Rattus norvegicus | Ki | = | 7120 | nM | 9371242 |
NPT1315 | Individual Protein | Adenosine A1 receptor | Rattus norvegicus | Ki | = | 15200 | nM | 9371242 |
NPT1315 | Individual Protein | Adenosine A1 receptor | Rattus norvegicus | Ratio | = | 2.1 | 9371242 | |
NPT24 | Organism | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | ED50 | > | 0.05 | nM | 3172142 |
NPT25 | Cell Line | MT4 | Homo sapiens | CD50 | = | 0.045 | nM | 3172142 |
NPT485 | Organism | Plasmodium falciparum (isolate K1 / Thailand) | Plasmodium falciparum K1 | IC50 | = | 4.5 | ug/ml | 15568800 |
NPT2 | Others | Unspecified | EC50 | = | 4100 | nM | PubChem BioAssay data set | |
NPT5055 | Individual Protein | Mitochondrial import inner membrane translocase subunit TIM23 | Saccharomyces cerevisiae S288c | IC50 | = | 14000 | nM | PubChem BioAssay data set |
NPT1273 | Individual Protein | ATP-dependent molecular chaperone HSP82 | Candida albicans (strain WO-1) (Yeast) | EC50 | > | 150000 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | 4466.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | EC50 | > | 150000 | nM | PubChem BioAssay data set | |
NPT1019 | Organism | Trichomonas vaginalis | Trichomonas vaginalis | GI | = | 94.1 | % | 22579483 |
NPT2 | Others | Unspecified | Potency | 44668.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10000 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 7307.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 8199.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Ki | = | 180 | nM | 24283924 | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | IC50 | >= | 100000 | nM | 24283924 |
NPT1018 | Organism | Trypanosoma brucei | Trypanosoma brucei | IC50 | = | 42 | nM | 24283924 |
NPT1018 | Organism | Trypanosoma brucei | Trypanosoma brucei | IC50 | = | 32 | nM | 24283924 |
NPT1460 | Cell Line | L929 | Mus musculus | IC50 | = | 28700 | nM | 24283924 |
NPT1018 | Organism | Trypanosoma brucei | Trypanosoma brucei | IC50 | = | 1.2 | nM | 24283924 |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | IC50 | = | 100 | nM | 24283924 |
NPT471 | Organism | Trypanosoma brucei brucei | Trypanosoma brucei brucei | IC50 | = | 30 | nM | 24283924 |
NPT191 | Organism | Hepatitis C virus | Hepatitis C virus | EC50 | = | 70000 | nM | 25282652 |
NPT2 | Others | Unspecified | CC50 | = | 13000 | nM | 25282652 | |
NPT2 | Others | Unspecified | Ratio CC50/EC50 | = | 0.19 | 25282652 | ||
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | > | 50118.72 | nM | 10.6019/CHEMBL3430912 |
NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | IC50 | = | 5011.87 | nM | 10.6019/CHEMBL3430912 |
NPT471 | Organism | Trypanosoma brucei brucei | Trypanosoma brucei brucei | IC50 | = | 12.59 | nM | 10.6019/CHEMBL3430912 |
NPT471 | Organism | Trypanosoma brucei brucei | Trypanosoma brucei brucei | IC50 | = | 10 | nM | 10.6019/CHEMBL3430912 |
NPT65 | Cell Line | HepG2 | Homo sapiens | IC50 | > | 100000 | nM | 10.6019/CHEMBL3430912 |
NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | IC50 | = | 1122.02 | nM | 10.6019/CHEMBL3430912 |
NPT886 | Cell Line | NIH3T3 | Mus musculus | IC50 | > | 50118.72 | nM | 10.6019/CHEMBL3430912 |
NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | IC50 | = | 1995.26 | nM | 10.6019/CHEMBL3430912 |
NPT2 | Others | Unspecified | IC50 | > | 100000 | nM | 10.6019/CHEMBL3430912 | |
NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | IC50 | = | 1258.93 | nM | 10.6019/CHEMBL3430912 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC229974 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9848 | High Similarity | NPC156461 |
0.9848 | High Similarity | NPC21448 |
0.9848 | High Similarity | NPC107374 |
0.9774 | High Similarity | NPC164665 |
0.9774 | High Similarity | NPC189068 |
0.9701 | High Similarity | NPC219313 |
0.9701 | High Similarity | NPC309832 |
0.9701 | High Similarity | NPC269827 |
0.9695 | High Similarity | NPC209525 |
0.9695 | High Similarity | NPC161659 |
0.9549 | High Similarity | NPC314152 |
0.9545 | High Similarity | NPC317821 |
0.942 | High Similarity | NPC185991 |
0.942 | High Similarity | NPC211025 |
0.942 | High Similarity | NPC85689 |
0.9353 | High Similarity | NPC321814 |
0.9353 | High Similarity | NPC472816 |
0.9323 | High Similarity | NPC129756 |
0.9286 | High Similarity | NPC164952 |
0.9286 | High Similarity | NPC212551 |
0.9286 | High Similarity | NPC130586 |
0.9286 | High Similarity | NPC302778 |
0.922 | High Similarity | NPC174802 |
0.9203 | High Similarity | NPC121222 |
0.9155 | High Similarity | NPC224076 |
0.9091 | High Similarity | NPC239737 |
0.9091 | High Similarity | NPC226245 |
0.9091 | High Similarity | NPC316618 |
0.9078 | High Similarity | NPC207633 |
0.9007 | High Similarity | NPC161224 |
0.9 | High Similarity | NPC136349 |
0.8936 | High Similarity | NPC150853 |
0.8828 | High Similarity | NPC311197 |
0.8828 | High Similarity | NPC54320 |
0.8828 | High Similarity | NPC313754 |
0.8824 | High Similarity | NPC33996 |
0.8811 | High Similarity | NPC328479 |
0.8784 | High Similarity | NPC323091 |
0.8759 | High Similarity | NPC52238 |
0.8676 | High Similarity | NPC320818 |
0.8514 | High Similarity | NPC195140 |
0.8446 | Intermediate Similarity | NPC93365 |
0.8421 | Intermediate Similarity | NPC261595 |
0.8366 | Intermediate Similarity | NPC321458 |
0.8366 | Intermediate Similarity | NPC324033 |
0.8333 | Intermediate Similarity | NPC326529 |
0.828 | Intermediate Similarity | NPC324198 |
0.828 | Intermediate Similarity | NPC319100 |
0.828 | Intermediate Similarity | NPC189261 |
0.8235 | Intermediate Similarity | NPC324484 |
0.8194 | Intermediate Similarity | NPC290959 |
0.8194 | Intermediate Similarity | NPC326082 |
0.8182 | Intermediate Similarity | NPC325906 |
0.8143 | Intermediate Similarity | NPC61198 |
0.8071 | Intermediate Similarity | NPC262926 |
0.7933 | Intermediate Similarity | NPC321052 |
0.7902 | Intermediate Similarity | NPC30326 |
0.7875 | Intermediate Similarity | NPC313897 |
0.7872 | Intermediate Similarity | NPC319221 |
0.7823 | Intermediate Similarity | NPC89147 |
0.7823 | Intermediate Similarity | NPC274384 |
0.7801 | Intermediate Similarity | NPC324009 |
0.7755 | Intermediate Similarity | NPC251233 |
0.7755 | Intermediate Similarity | NPC211820 |
0.774 | Intermediate Similarity | NPC186619 |
0.7703 | Intermediate Similarity | NPC177169 |
0.7651 | Intermediate Similarity | NPC64705 |
0.7651 | Intermediate Similarity | NPC24589 |
0.7651 | Intermediate Similarity | NPC232408 |
0.7635 | Intermediate Similarity | NPC318590 |
0.7619 | Intermediate Similarity | NPC78941 |
0.7619 | Intermediate Similarity | NPC282458 |
0.7584 | Intermediate Similarity | NPC317746 |
0.7568 | Intermediate Similarity | NPC74306 |
0.7568 | Intermediate Similarity | NPC315642 |
0.7566 | Intermediate Similarity | NPC326694 |
0.7412 | Intermediate Similarity | NPC313514 |
0.7391 | Intermediate Similarity | NPC33382 |
0.7346 | Intermediate Similarity | NPC168702 |
0.7346 | Intermediate Similarity | NPC125659 |
0.7256 | Intermediate Similarity | NPC222174 |
0.7205 | Intermediate Similarity | NPC14590 |
0.7143 | Intermediate Similarity | NPC321393 |
0.7121 | Intermediate Similarity | NPC476564 |
0.7111 | Intermediate Similarity | NPC276373 |
0.7075 | Intermediate Similarity | NPC57279 |
0.7072 | Intermediate Similarity | NPC5802 |
0.7071 | Intermediate Similarity | NPC327579 |
0.7033 | Intermediate Similarity | NPC157821 |
0.7023 | Intermediate Similarity | NPC174114 |
0.7023 | Intermediate Similarity | NPC87981 |
0.6939 | Remote Similarity | NPC246193 |
0.6939 | Remote Similarity | NPC104011 |
0.6861 | Remote Similarity | NPC4837 |
0.6861 | Remote Similarity | NPC312187 |
0.6828 | Remote Similarity | NPC248007 |
0.6701 | Remote Similarity | NPC250178 |
0.6621 | Remote Similarity | NPC139776 |
0.6618 | Remote Similarity | NPC18335 |
0.66 | Remote Similarity | NPC287876 |
0.6533 | Remote Similarity | NPC14330 |
0.6524 | Remote Similarity | NPC472834 |
0.6489 | Remote Similarity | NPC103388 |
0.6468 | Remote Similarity | NPC107160 |
0.6419 | Remote Similarity | NPC109322 |
0.6373 | Remote Similarity | NPC160666 |
0.6373 | Remote Similarity | NPC21461 |
0.6345 | Remote Similarity | NPC68938 |
0.628 | Remote Similarity | NPC158055 |
0.6211 | Remote Similarity | NPC217656 |
0.6173 | Remote Similarity | NPC89139 |
0.6164 | Remote Similarity | NPC296437 |
0.6138 | Remote Similarity | NPC313547 |
0.6133 | Remote Similarity | NPC5707 |
0.6125 | Remote Similarity | NPC470266 |
0.6124 | Remote Similarity | NPC164845 |
0.6122 | Remote Similarity | NPC189314 |
0.6115 | Remote Similarity | NPC476561 |
0.6061 | Remote Similarity | NPC244700 |
0.6053 | Remote Similarity | NPC180493 |
0.6049 | Remote Similarity | NPC476433 |
0.6049 | Remote Similarity | NPC476528 |
0.6012 | Remote Similarity | NPC476522 |
0.6012 | Remote Similarity | NPC476013 |
0.6012 | Remote Similarity | NPC476520 |
0.6012 | Remote Similarity | NPC474986 |
0.6 | Remote Similarity | NPC472833 |
0.6 | Remote Similarity | NPC476408 |
0.5978 | Remote Similarity | NPC265111 |
0.5976 | Remote Similarity | NPC476521 |
0.5934 | Remote Similarity | NPC473585 |
0.5915 | Remote Similarity | NPC476099 |
0.5896 | Remote Similarity | NPC472832 |
0.5896 | Remote Similarity | NPC18308 |
0.5874 | Remote Similarity | NPC119133 |
0.5871 | Remote Similarity | NPC180462 |
0.5804 | Remote Similarity | NPC476562 |
0.5745 | Remote Similarity | NPC293163 |
0.5743 | Remote Similarity | NPC256849 |
0.5734 | Remote Similarity | NPC59314 |
0.5714 | Remote Similarity | NPC47936 |
0.5671 | Remote Similarity | NPC210947 |
0.5667 | Remote Similarity | NPC63433 |
0.5655 | Remote Similarity | NPC327477 |
0.5644 | Remote Similarity | NPC470141 |
0.5638 | Remote Similarity | NPC41958 |
0.5638 | Remote Similarity | NPC303899 |
0.5625 | Remote Similarity | NPC10466 |
0.5617 | Remote Similarity | NPC126634 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC229974 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9848 | High Similarity | NPD249 | Approved |
0.9848 | High Similarity | NPD250 | Approved |
0.9701 | High Similarity | NPD195 | Approved |
0.9701 | High Similarity | NPD186 | Discovery |
0.9549 | High Similarity | NPD185 | Approved |
0.9545 | High Similarity | NPD193 | Suspended |
0.942 | High Similarity | NPD283 | Approved |
0.9407 | High Similarity | NPD166 | Approved |
0.9286 | High Similarity | NPD1750 | Clinical (unspecified phase) |
0.9286 | High Similarity | NPD242 | Approved |
0.9286 | High Similarity | NPD3107 | Discontinued |
0.9286 | High Similarity | NPD338 | Approved |
0.9286 | High Similarity | NPD1369 | Phase 2 |
0.922 | High Similarity | NPD339 | Approved |
0.9155 | High Similarity | NPD169 | Phase 2 |
0.9091 | High Similarity | NPD2646 | Discontinued |
0.9091 | High Similarity | NPD2624 | Phase 2 |
0.9091 | High Similarity | NPD1732 | Phase 3 |
0.9 | High Similarity | NPD548 | Clinical (unspecified phase) |
0.8828 | High Similarity | NPD219 | Phase 3 |
0.8828 | High Similarity | NPD216 | Approved |
0.8828 | High Similarity | NPD217 | Approved |
0.8828 | High Similarity | NPD220 | Clinical (unspecified phase) |
0.8828 | High Similarity | NPD218 | Approved |
0.875 | High Similarity | NPD214 | Approved |
0.875 | High Similarity | NPD213 | Clinical (unspecified phase) |
0.8609 | High Similarity | NPD2647 | Phase 3 |
0.8582 | High Similarity | NPD248 | Discontinued |
0.8446 | Intermediate Similarity | NPD546 | Clinical (unspecified phase) |
0.8433 | Intermediate Similarity | NPD870 | Clinical (unspecified phase) |
0.8421 | Intermediate Similarity | NPD247 | Clinical (unspecified phase) |
0.8333 | Intermediate Similarity | NPD5666 | Phase 2 |
0.8309 | Intermediate Similarity | NPD9632 | Phase 3 |
0.8301 | Intermediate Similarity | NPD7988 | Suspended |
0.828 | Intermediate Similarity | NPD4171 | Clinical (unspecified phase) |
0.8228 | Intermediate Similarity | NPD1412 | Clinical (unspecified phase) |
0.8182 | Intermediate Similarity | NPD1776 | Approved |
0.8182 | Intermediate Similarity | NPD1777 | Approved |
0.8143 | Intermediate Similarity | NPD252 | Clinical (unspecified phase) |
0.8125 | Intermediate Similarity | NPD4716 | Approved |
0.8105 | Intermediate Similarity | NPD3083 | Approved |
0.8075 | Intermediate Similarity | NPD4744 | Clinical (unspecified phase) |
0.8039 | Intermediate Similarity | NPD516 | Clinical (unspecified phase) |
0.7975 | Intermediate Similarity | NPD1692 | Approved |
0.7943 | Intermediate Similarity | NPD194 | Clinical (unspecified phase) |
0.7917 | Intermediate Similarity | NPD549 | Approved |
0.7879 | Intermediate Similarity | NPD5682 | Phase 3 |
0.7879 | Intermediate Similarity | NPD6417 | Clinical (unspecified phase) |
0.7879 | Intermediate Similarity | NPD5684 | Clinical (unspecified phase) |
0.7879 | Intermediate Similarity | NPD5683 | Clinical (unspecified phase) |
0.7842 | Intermediate Similarity | NPD9633 | Phase 3 |
0.7784 | Intermediate Similarity | NPD2631 | Clinical (unspecified phase) |
0.7784 | Intermediate Similarity | NPD2632 | Approved |
0.7784 | Intermediate Similarity | NPD2630 | Approved |
0.7754 | Intermediate Similarity | NPD9408 | Phase 3 |
0.7703 | Intermediate Similarity | NPD7158 | Phase 1 |
0.7697 | Intermediate Similarity | NPD536 | Clinical (unspecified phase) |
0.7568 | Intermediate Similarity | NPD582 | Approved |
0.7566 | Intermediate Similarity | NPD3708 | Phase 2 |
0.7412 | Intermediate Similarity | NPD7138 | Phase 2 |
0.7355 | Intermediate Similarity | NPD231 | Clinical (unspecified phase) |
0.7342 | Intermediate Similarity | NPD4074 | Clinical (unspecified phase) |
0.7338 | Intermediate Similarity | NPD3085 | Phase 1 |
0.729 | Intermediate Similarity | NPD3086 | Phase 3 |
0.72 | Intermediate Similarity | NPD3695 | Approved |
0.72 | Intermediate Similarity | NPD3696 | Approved |
0.7182 | Intermediate Similarity | NPD2965 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD2876 | Phase 3 |
0.7143 | Intermediate Similarity | NPD2877 | Clinical (unspecified phase) |
0.7134 | Intermediate Similarity | NPD9605 | Phase 3 |
0.7126 | Intermediate Similarity | NPD4054 | Clinical (unspecified phase) |
0.7122 | Intermediate Similarity | NPD9606 | Approved |
0.7071 | Intermediate Similarity | NPD9607 | Approved |
0.7065 | Intermediate Similarity | NPD2824 | Phase 2 |
0.7027 | Intermediate Similarity | NPD209 | Clinical (unspecified phase) |
0.7013 | Intermediate Similarity | NPD171 | Discontinued |
0.7 | Intermediate Similarity | NPD1046 | Clinical (unspecified phase) |
0.6959 | Remote Similarity | NPD545 | Clinical (unspecified phase) |
0.6915 | Remote Similarity | NPD2903 | Clinical (unspecified phase) |
0.6915 | Remote Similarity | NPD2902 | Phase 2 |
0.6906 | Remote Similarity | NPD9374 | Approved |
0.6884 | Remote Similarity | NPD9373 | Approved |
0.6867 | Remote Similarity | NPD1119 | Phase 2 |
0.6859 | Remote Similarity | NPD1730 | Discontinued |
0.6848 | Remote Similarity | NPD527 | Clinical (unspecified phase) |
0.6846 | Remote Similarity | NPD547 | Clinical (unspecified phase) |
0.6839 | Remote Similarity | NPD4240 | Approved |
0.6831 | Remote Similarity | NPD307 | Approved |
0.6828 | Remote Similarity | NPD9084 | Phase 2 |
0.6809 | Remote Similarity | NPD4495 | Phase 1 |
0.6761 | Remote Similarity | NPD1063 | Phase 2 |
0.675 | Remote Similarity | NPD353 | Discontinued |
0.6689 | Remote Similarity | NPD1058 | Discontinued |
0.6667 | Remote Similarity | NPD775 | Approved |
0.6667 | Remote Similarity | NPD282 | Approved |
0.6667 | Remote Similarity | NPD9584 | Phase 2 |
0.6618 | Remote Similarity | NPD8836 | Approved |
0.6604 | Remote Similarity | NPD7531 | Clinical (unspecified phase) |
0.6603 | Remote Similarity | NPD2253 | Discontinued |
0.66 | Remote Similarity | NPD8829 | Clinical (unspecified phase) |
0.6592 | Remote Similarity | NPD207 | Discontinued |
0.6579 | Remote Similarity | NPD9083 | Clinical (unspecified phase) |
0.6554 | Remote Similarity | NPD281 | Approved |
0.6516 | Remote Similarity | NPD799 | Phase 1 |
0.6513 | Remote Similarity | NPD5080 | Phase 2 |
0.65 | Remote Similarity | NPD2152 | Clinical (unspecified phase) |
0.6497 | Remote Similarity | NPD1430 | Approved |
0.6497 | Remote Similarity | NPD1431 | Approved |
0.6471 | Remote Similarity | NPD4458 | Phase 2 |
0.6471 | Remote Similarity | NPD4459 | Clinical (unspecified phase) |
0.6467 | Remote Similarity | NPD1128 | Approved |
0.6467 | Remote Similarity | NPD1127 | Approved |
0.6462 | Remote Similarity | NPD5079 | Phase 2 |
0.6433 | Remote Similarity | NPD1118 | Discontinued |
0.6419 | Remote Similarity | NPD798 | Discontinued |
0.6346 | Remote Similarity | NPD6112 | Approved |
0.6338 | Remote Similarity | NPD9375 | Discontinued |
0.6327 | Remote Similarity | NPD9409 | Discontinued |
0.6323 | Remote Similarity | NPD9484 | Clinical (unspecified phase) |
0.6306 | Remote Similarity | NPD1808 | Phase 1 |
0.6294 | Remote Similarity | NPD2593 | Clinical (unspecified phase) |
0.6286 | Remote Similarity | NPD1816 | Clinical (unspecified phase) |
0.6282 | Remote Similarity | NPD535 | Approved |
0.628 | Remote Similarity | NPD6840 | Approved |
0.6259 | Remote Similarity | NPD9626 | Clinical (unspecified phase) |
0.625 | Remote Similarity | NPD1117 | Clinical (unspecified phase) |
0.6241 | Remote Similarity | NPD9416 | Phase 3 |
0.6241 | Remote Similarity | NPD9417 | Phase 3 |
0.6184 | Remote Similarity | NPD515 | Phase 1 |
0.6178 | Remote Similarity | NPD5486 | Discontinued |
0.6178 | Remote Similarity | NPD1120 | Approved |
0.6178 | Remote Similarity | NPD1121 | Approved |
0.6133 | Remote Similarity | NPD8830 | Phase 3 |
0.6124 | Remote Similarity | NPD7502 | Clinical (unspecified phase) |
0.6122 | Remote Similarity | NPD8831 | Approved |
0.6122 | Remote Similarity | NPD8833 | Approved |
0.6096 | Remote Similarity | NPD757 | Phase 3 |
0.6082 | Remote Similarity | NPD5458 | Discontinued |
0.6053 | Remote Similarity | NPD9544 | Approved |
0.6053 | Remote Similarity | NPD78 | Approved |
0.6 | Remote Similarity | NPD691 | Discontinued |
0.5991 | Remote Similarity | NPD8250 | Phase 2 |
0.5986 | Remote Similarity | NPD9406 | Approved |
0.5974 | Remote Similarity | NPD1775 | Approved |
0.5974 | Remote Similarity | NPD1085 | Approved |
0.5973 | Remote Similarity | NPD9360 | Approved |
0.5969 | Remote Similarity | NPD796 | Phase 2 |
0.596 | Remote Similarity | NPD2221 | Clinical (unspecified phase) |
0.5952 | Remote Similarity | NPD7842 | Phase 2 |
0.5915 | Remote Similarity | NPD9704 | Approved |
0.5906 | Remote Similarity | NPD1017 | Clinical (unspecified phase) |
0.5906 | Remote Similarity | NPD1368 | Approved |
0.5874 | Remote Similarity | NPD9291 | Approved |
0.5867 | Remote Similarity | NPD237 | Clinical (unspecified phase) |
0.5867 | Remote Similarity | NPD578 | Discontinued |
0.5833 | Remote Similarity | NPD1354 | Approved |
0.5833 | Remote Similarity | NPD1356 | Approved |
0.5833 | Remote Similarity | NPD1355 | Clinical (unspecified phase) |
0.5828 | Remote Similarity | NPD580 | Discontinued |
0.5814 | Remote Similarity | NPD3849 | Clinical (unspecified phase) |
0.5805 | Remote Similarity | NPD4555 | Clinical (unspecified phase) |
0.5805 | Remote Similarity | NPD537 | Phase 2 |
0.5805 | Remote Similarity | NPD534 | Phase 2 |
0.5802 | Remote Similarity | NPD5627 | Approved |
0.5775 | Remote Similarity | NPD3913 | Clinical (unspecified phase) |
0.5773 | Remote Similarity | NPD5665 | Clinical (unspecified phase) |
0.5753 | Remote Similarity | NPD613 | Phase 2 |
0.5743 | Remote Similarity | NPD9359 | Approved |
0.5743 | Remote Similarity | NPD9358 | Approved |
0.5742 | Remote Similarity | NPD579 | Clinical (unspecified phase) |
0.5739 | Remote Similarity | NPD5768 | Phase 2 |
0.5734 | Remote Similarity | NPD8837 | Clinical (unspecified phase) |
0.5691 | Remote Similarity | NPD5757 | Discontinued |
0.5691 | Remote Similarity | NPD2591 | Phase 2 |
0.5686 | Remote Similarity | NPD9290 | Approved |
0.5676 | Remote Similarity | NPD5171 | Clinical (unspecified phase) |
0.5673 | Remote Similarity | NPD6381 | Phase 2 |
0.5669 | Remote Similarity | NPD9366 | Approved |
0.5668 | Remote Similarity | NPD2457 | Phase 2 |
0.5668 | Remote Similarity | NPD2456 | Phase 2 |
0.5663 | Remote Similarity | NPD4599 | Clinical (unspecified phase) |
0.5659 | Remote Similarity | NPD4089 | Clinical (unspecified phase) |
0.5657 | Remote Similarity | NPD4715 | Clinical (unspecified phase) |
0.5657 | Remote Similarity | NPD34 | Approved |
0.5657 | Remote Similarity | NPD4714 | Approved |
0.5657 | Remote Similarity | NPD4713 | Clinical (unspecified phase) |
0.5644 | Remote Similarity | NPD9551 | Approved |
0.5644 | Remote Similarity | NPD9550 | Approved |
0.5642 | Remote Similarity | NPD5269 | Clinical (unspecified phase) |
0.5613 | Remote Similarity | NPD4262 | Discontinued |
0.5603 | Remote Similarity | NPD6023 | Discontinued |
0.56 | Remote Similarity | NPD7323 | Phase 2 |
0.56 | Remote Similarity | NPD3697 | Discontinued |
PubChem CID   | 6303 |
ChEMBL   | CHEMBL305686 |
ZINC   |
Molecular Weight:   | 251.10 |
ALogP:   | -2.0564 |
MLogP:   | 1.68 |
XLogP:   | -1.637 |
# Rotatable Bonds:   | 5 |
Polar Surface Area:   | 119.31 |
# H-Bond Aceptor:   | 8 |
# H-Bond Donor:   | 3 |
# Rings:   | 3 |
# Heavy Atoms:   | 18 |